International Rare Disease Day: Focus on IgG4-Related Diseases
On February 28, International Rare Disease Day raises awareness of rare diseases and improves access to diagnosis, treatment, and care for those affected. IgG4-related disease, characterized by an abnormal increase in IgG4 concentrations in the blood and tissue, is one such rare disease.
IgG4-related disease can affect various organs, including the pancreas, kidneys, and salivary glands. Symptoms can vary, making it challenging to diagnose, but early and accurate diagnosis is crucial for effective treatment and management of the disease.
Efforts to increase awareness of IgG4-related disease and advocate for better care and treatment for those affected are critical in improving the understanding and management of this rare disease. International Rare Disease Day serves as a reminder to healthcare professionals, patients, and society as a whole to join together for better care and support for those living with rare diseases.
By raising awareness of IgG4-related disease and improving access to diagnosis, treatment, and care, we can better support those affected by this rare disease and improve outcomes.
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
